Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-478-9
CAS number: -
In an oral OECD 421 screening study rats were given 0, 100, 500 or 1000
mg/kg bw/d of URALAC P 1910C/URALAC P 1920C formulated in propylene
glycol for 7 days/week for 28 days (males) and 41 -45 days (females). No
adverse effects were observed on mortality, clinical signs, body weight(
gain) and food consumption, macroscopy and histopathology. Reproduction
parameters consisting of mating, fertility and conception indices,
precoital time, number of corpora lutea and implantation sites,
gestation index and duration, parturition and maternal care showed no
effects. Sex ratio and early postnatal pup development (mortality,
clinical signs, body weight and macroscopy) were not affected.
Based on the absence of adverse effects, the NOAEL for maternal and
developmental toxicity was determined to be at least 1000 mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again